Impedance Spectroscopy and Transcriptome Analysis of Choriocarcinoma BeWo b30 as a Model of Human Placenta
- Authors: Nikulin S.V.1,2, Knyazev E.N.1, Gerasimenko T.N.1, Shilin S.A.1, Gazizov I.N.1, Zakharova G.S.1, Poloznikov A.A.3, Sakharov D.A.1
-
Affiliations:
- OOO SRC Bioclinicum
- Moscow Institute of Physics and Technology (State University)
- National Medical Research Radiological Center, Ministry of Health of the Russian Federation
- Issue: Vol 53, No 3 (2019)
- Pages: 411-418
- Section: Molecular Cell Biology
- URL: https://journal-vniispk.ru/0026-8933/article/view/163953
- DOI: https://doi.org/10.1134/S0026893319030130
- ID: 163953
Cite item
Abstract
Placenta is a highly specialized organ that is necessary for successful gestation. Several models of the placental barrier are used to study how it functions, including the transplacental transport of xenobiotics. One of these models, human choriocarcinoma cell line BeWo is widely used in vitro. Notably, cancerous BeWo cells form multilayer structures that normally are not found in the human placenta. Here, we aim to develop techniques suitable for monitoring BeWo b30 cells in culture. To assess the state of BeWo b30 cells growing on a membrane, we use impedance spectroscopy, which allows us to estimate the number of cell layers by the change in the electrical parameters of the biological system. In mature BeWo b30 cell cultures, we also note a significant increase in the expression of genes encoding metallothioneins (particularly, MT1B, MT1F, and MT2A) and syncytins (ERVW-1 and ERVFRD-1), which can be used as biomarkers reflecting the development of mature phenotypic characteristics, namely, trophoblastic invasion and formation of the syncytium.
About the authors
S. V. Nikulin
OOO SRC Bioclinicum; Moscow Institute of Physics and Technology (State University)
Author for correspondence.
Email: s.nikulin@bioclinicum.com
Russian Federation, Moscow, 115088; Dolgoprudny, Moscow oblast, 141701
E. N. Knyazev
OOO SRC Bioclinicum
Email: s.nikulin@bioclinicum.com
Russian Federation, Moscow, 115088
T. N. Gerasimenko
OOO SRC Bioclinicum
Email: s.nikulin@bioclinicum.com
Russian Federation, Moscow, 115088
S. A. Shilin
OOO SRC Bioclinicum
Email: s.nikulin@bioclinicum.com
Russian Federation, Moscow, 115088
I. N. Gazizov
OOO SRC Bioclinicum
Email: s.nikulin@bioclinicum.com
Russian Federation, Moscow, 115088
G. S. Zakharova
OOO SRC Bioclinicum
Email: s.nikulin@bioclinicum.com
Russian Federation, Moscow, 115088
A. A. Poloznikov
National Medical Research Radiological Center, Ministry of Health of the Russian Federation
Email: s.nikulin@bioclinicum.com
Russian Federation, Obninsk, Kaluga oblast, 249036
D. A. Sakharov
OOO SRC Bioclinicum
Email: s.nikulin@bioclinicum.com
Russian Federation, Moscow, 115088
Supplementary files
